Diagonal Bio AB (publ) (NGM:DIABIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0080
0.00 (0.00%)
At close: Jul 25, 2025

Diagonal Bio AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1.361.133.153.718.678
Revenue Growth (YoY)
-42.73%-64.30%-14.98%-57.26%8.41%-
Cost of Revenue
0.330.180.021.658.768.07
Gross Profit
1.030.943.132.05-0.09-0.07
Selling, General & Admin
8.959.3614.6817.2211.550.74
Other Operating Expenses
0-00.02-00.03-0.03
Operating Expenses
10.2510.3614.717.2211.580.71
Operating Income
-9.22-9.42-11.57-15.16-11.66-0.78
Interest Expense
-0.32-0.58-0.21-1--
Interest & Investment Income
0.080.080.09---
Other Non Operating Income (Expenses)
--0---
Pretax Income
-9.47-9.93-11.68-16.16-11.66-0.78
Net Income
-9.47-9.93-11.68-16.16-11.66-0.78
Net Income to Common
-9.47-9.93-11.68-16.16-11.66-0.78
Shares Outstanding (Basic)
45627636974
Shares Outstanding (Diluted)
45627636974
Shares Change (YoY)
1106.71%655.26%284.00%38.15%96.47%-
EPS (Basic)
-0.02-0.04-0.32-1.70-1.70-0.22
EPS (Diluted)
-0.02-0.04-0.32-1.70-1.70-0.22
Gross Margin
75.77%83.73%99.43%55.42%-0.98%-0.87%
Operating Margin
-679.16%-837.42%-367.09%-409.15%-134.52%-9.72%
Profit Margin
-697.35%-882.67%-370.61%-436.16%-134.52%-9.72%
EBITDA
-8.74-9.23-11.56---
D&A For EBITDA
0.490.190---
EBIT
-9.22-9.42-11.57-15.16-11.66-0.78
EBIT Margin
-----134.52%-9.72%
Revenue as Reported
1.361.133.183.738.728.12
Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.